BIORESTORATIVE THERAPIES INC
BRTXNASDAQ🏆 #3740 by market capEarnings Nov 10US Equity
$0.22▲ $0.01 (+4.89%)
Live1h—
24h▲ 4.9%
7d▲ 1.4%
14d▼ 19.5%
30d▼ 35.1%
1y▼ 85.4%
🏦Market Cap
$6M
Small Cap
📈Revenue Growth (YoY)
-8.5%
Declining
📊Gross Margin
92.1%
High
💵FCF Margin
—
⚖️P/S Ratio
14.3x
Expensive
Otter Score
42
Weak
Trading Snapshot
- Day Range
- $0.21 – $0.22
- 52-Week Range
- $0.16 – $1.89
- Volume
- $2.42B
- Avg Volume
- $1.73B
- Shares Outstanding
- 25.5M
- Next Earnings
- Oct 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $357,869
- Last Q Revenue
- $90,701
- P/E Ratio
- —
- P/S Ratio
- 14.3x
- EPS (TTM)
- $-1.09
- Dividend Yield
- —
Why Investors Own BRTX
- ✓High-growth profile — revenue up +36.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 58% gross margin and 15% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$357,869▲ +36.6% YoY
Gross Margin (TTM)
58.0%▲ +2.0% YoY
Operating Income (TTM)
$96,267▲ +36.6% YoY
Free Cash Flow (TTM)
$54,038▲ +36.6% YoY
About BIORESTORATIVE THERAPIES INC
A company profile for BIORESTORATIVE THERAPIES INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
42/100
Analyst Ratings
ⓘConsensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026
Latest News & Updates
Benzinga·4d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's after-market session. The company's market cap stands at $1.9 billion. As per the news, the Q2 earnings report came out
Benzinga·11d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-market session. Moleculin Biotech (NASDAQ:MBRX) shares increased by 17.64% to $1.2. The market value of their
🌌
Benzinga·26d ago
BioRestorative Therapies Says Lance Alstodt Resigns As President, CEO, Chairman And All Other Positions Effective July 13, 2026; Robert Kristal Resigns As CFO And All Other Positions; Katharyn Field Appointed As CEO, President, And Interim CFO
https://ir.biorestorative.com/sec-filings/all-sec-filings/content/0001493152-26-033593/form8-k.htm